PXINX
Price
$11.19
Change
-$0.07 (-0.62%)
Updated
Feb 21 closing price
Net Assets
1.3B
VGTSX
Price
$20.15
Change
-$0.12 (-0.59%)
Updated
Feb 21 closing price
Net Assets
445.3B
Ad is loading...

PXINX vs VGTSX

Header iconPXINX vs VGTSX Comparison
Open Charts PXINX vs VGTSXBanner chart's image
Impax International Sust Econ I
Price$11.19
Change-$0.07 (-0.62%)
VolumeN/A
Net Assets1.3B
Vanguard Total Intl Stock Index I
Price$20.15
Change-$0.12 (-0.59%)
VolumeN/A
Net Assets445.3B
PXINX vs VGTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PXINX vs. VGTSX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXINX is a Buy and VGTSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VGTSX has more cash in the bank: 445B vs. PXINX (1.3B). VGTSX pays higher dividends than PXINX: VGTSX (3.20) vs PXINX (1.99). PXINX was incepted earlier than VGTSX: PXINX (11 years) vs VGTSX (29 years). PXINX is a more actively managed with annual turnover of: 56.00 vs. VGTSX (4.00). VGTSX has a lower initial minimum investment than PXINX: VGTSX (0) vs PXINX (1000). PXINX annual gain was more profitable for investors over the last year : 9.20 vs. VGTSX (7.53). PXINX return over 5 years is better than : 31.39 vs. VGTSX (19.60).
PXINXVGTSXPXINX / VGTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years29 years-
Gain YTD7.4936.332118%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B445B0%
Annual Yield % from dividends1.993.2062%
Returns for 1 year9.207.53122%
Returns for 3 years17.635.91298%
Returns for 5 years31.3919.60160%
Returns for 10 years58.4532.54180%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSS0.940.02
+2.17%
DSS
ALEC1.870.01
+0.54%
Alector
SHOO38.23-0.47
-1.21%
Steven Madden Ltd
BCYC11.66-0.34
-2.83%
Bicycle Therapeutics plc
SMMT22.12-0.94
-4.08%
Summit Therapeutics